Author:
Kirby Karen A.,Michailidis Eleftherios,Fetterly Tracy L.,Steinbach Musetta A.,Singh Kamalendra,Marchand Bruno,Leslie Maxwell D.,Hagedorn Ariel N.,Kodama Eiichi N.,Marquez Victor E.,Hughes Stephen H.,Mitsuya Hiroaki,Parniak Michael A.,Sarafianos Stefan G.
Abstract
ABSTRACTNucleos(t)ide reverse transcriptase inhibitors (NRTIs) form the backbone of most anti-HIV therapies. We have shown that 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) is a highly effective NRTI; however, the reasons for the potent antiviral activity of EFdA are not well understood. Here, we use a combination of structural, computational, and biochemical approaches to examine how substitutions in the sugar or adenine rings affect the incorporation of dA-based NRTIs like EFdA into DNA by HIV RT and their susceptibility to deamination by adenosine deaminase (ADA). Nuclear magnetic resonance (NMR) spectroscopy studies of 4′-substituted NRTIs show that ethynyl or cyano groups stabilize the sugar ring in the C-2′-exo/C-3′-endo (north) conformation. Steady-state kinetic analysis of the incorporation of 4′-substituted NRTIs by RT reveals a correlation between the north conformation of the NRTI sugar ring and efficiency of incorporation into the nascent DNA strand. Structural analysis and the kinetics of deamination by ADA demonstrate that 4′-ethynyl and cyano substitutions decrease the susceptibility of adenosine-based compounds to ADA through steric interactions at the active site. However, the major determinant for decreased susceptibility to ADA is the 2-halo substitution, which alters the pKaof N1 on the adenine base. These results provide insight into how NRTI structural attributes affect their antiviral activities through their interactions with the RT and ADA active sites.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference71 articles.
1. Inhibitors of HIV-1 reverse transcriptase;Parniak;Adv. Pharmacol.,2000
2. Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase;Painter;Curr. Top. Med. Chem.,2004
3. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society—U. S;Hammer;A. panel. Top. HIV Med.,2006
4. Anti-HIV drugs;De Clercq;Verh. K. Acad. Geneeskd. Belg.,2007
5. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition;Sarafianos;J. Mol. Biol.,2009
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献